"Incredible Confusion" Over Statute's Safety And Effectiveness Instructions
This article was originally published in The Gray Sheet
Executive Summary
IOM, industry and FDA disagree on the IOM committee's fundamental premise that the 510(k) program does not provide an assurance of safety and effectiveness.